Glynase Related Clinical Trials
Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus. [Terminated]
A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Glyburide in Healthy Volunteers [Completed]
Glyburide Healthy Volunteer Study [Completed]
Glyburide (RP-1127) for Traumatic Brain Injury (TBI) [Active, not recruiting]
Glyburide and Metformin for the Treatment of Gestational Diabetes Mellitus. Systematic Review [Completed]
Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension [Recruiting]
Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes [Recruiting]
Bioavailability of BI 1356 and Glyburide in Healthy Male and Female Volunteers [Completed]
A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions [Completed]
A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions [Completed]
A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting Conditions [Completed]
Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed [Completed]
Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting [Completed]
Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type 2 Diabetes Mellitus [Completed]
Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (GCC 1465) [Not yet recruiting]
Interplay Between Organic Anion Transporting Polypeptide (OATP) Transporters Transporters and CYP2C9 in Glyburide Pharmacokinetics (PK) [Withdrawn]
Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes [Completed]
Glyburide and Metformin for Gestational Diabetes Mellitus (GDM) [Active, not recruiting]
Metformin Compared to Glyburide in Gestational Diabetes [Completed]
Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease [Completed]
R230C and C230C Variants of ABCA1 and Glyburide Response [Completed]
Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355) [Recruiting]
Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational Diabetes [Withdrawn]
Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DM [Completed]
Glyburide Advantage in Malignant Edema and Stroke Pilot [Completed]
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide [Completed]
Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational Diabetes [Recruiting]
Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM [Completed]
Safety Study of Pioglitazone Compared To Glyburide on Liver Function [Completed]
Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure [Terminated]
Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo [Active, not recruiting]
Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes [Not yet recruiting]
Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus. [Completed]
A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes. [Completed]
Risk of Hypoglycemia in Type 2 Diabetes [Active, not recruiting]
Glycemic Profile in Women With Gestational Diabetes Treated With Glyburide [Recruiting]
A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS [Recruiting]
A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes Mellitus [Enrolling by invitation]
Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients [Completed]
Glyburide Opportunity for Spinal Cord Injury Protection [Recruiting]
Safety Study of RP-1127 (Glyburide for Injection) in Healthy Volunteers [Completed]
AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone [Completed]
Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels [Not yet recruiting]
GALLANT 4 Tesaglitazar vs. Glibenclamide [Terminated]
Cardioprotective Effects of GLP-1 and Their Mechanisms [Not yet recruiting]
Oral Antidiabetic Agents in Pregnancy [Recruiting]
A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas [Completed]
Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury [Recruiting]
Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes [Terminated]
Preferred Treatment of Type 1.5 Diabetes [Completed]
Gestational Diabetes: Insulin or Oral Hypoglycemic Agents? [Active, not recruiting]
Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study [Recruiting]
Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus [Completed]
Preservation of Beta-cell Function in Type 2 Diabetes Mellitus [Completed]
A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes [Completed]
The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation [Recruiting]
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes [Completed]
A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus [Terminated]
Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes [Completed]
Efficacy of Repaglinide in Subjects With Type 2 Diabetes [Completed]
A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes. [Completed]
To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies [Completed]
Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus. [Completed]
A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion [Completed]
Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet [Completed]
Evaluation of Cissus Verticillata L. Infusion in Controlling Type 2 Diabetes [Completed]
Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM [Recruiting]
Comparison of Glucovance to Insulin for Diabetes During Pregnancy [Recruiting]
PPAR-COMBO With Sulfonylurea [Completed]
GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes [Terminated]
Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia [Completed]
Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus [Recruiting]
Pharmacogenetic Effect on the Pharmacodynamics of Glibenclamide [Recruiting]
Insulin Glargine in Type 2 Diabetic Patients [Completed]
Incretin and KATP Channels [Recruiting]
Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial [Active, not recruiting]
MK-3102 Phase III Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015 AM1) [Completed]
Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 Diabetes [Completed]
Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment [Completed]
Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy [Active, not recruiting]
Ischemic Injury and Ischemic Preconditioning in Diabetes [Completed]
GALLANT 7 Tesaglitazar Add-on to Sulphonylurea [Terminated]
Malignancy Meta Analysis for BRL49653 [Completed]
Incretin-based Drugs and Acute Pancreatitis [Completed]
Incretin-based Drugs and Pancreatic Cancer [Completed]
Incretin-based Drugs and the Risk of Heart Failure [Completed]
A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients [Completed]
Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers [Completed]
Rosiglitazone on Microalbuminuria in Type 2 Diabetics [Completed]
A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus [Completed]
Fracture Risk With Thiazolidinediones [Completed]
Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes [Withdrawn]
Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea [Not yet recruiting]
A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes [Completed]
Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263) [Completed]
Dietary Supplement of LEHEL for the Patients With Type 2 Diabetes [Completed]
An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (JanuviaŽ/XeleviaŽ, MK-0431-201) [Completed]
|